Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer
PLOS One · 02.05.2025 · 20 (5) · e0322618
DOI: 10.1371/journal.pone.0322618 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 02.05.2025. Verfasst von Heming Ge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Macrophages, Hypoxia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a low survival rate and limited responsiveness to current therapies. The role of hypoxia in the tumor microenvironment is critical, influencing tumor progression and therapy resistance. The aim of this study was to implement the complex dynamics of the hypoxic tumor microenvironment in PDAC in a hypoxia-related prognosis model.
Methods
We utilized single-cell RNA sequencing (scRNA-seq) data and integrated it with TCGA-PAAD database to identify hypoxia-responsive macrophage subsets and related genes. Kaplan-Meier survival analysis, Cox regression, and Lasso regression methods were employed to construct and validate a hypoxia-related prognostic model. The model’s effectiveness was evaluated through its predictive capabilities regarding chemotherapy sensitivity and overall survival.
Results
Our research integrated data from scRNA-seq and the TCGA-PAAD database to construct a hypoxia-related prognostic model that encompassed 13 critical genes. This hypoxia model independently predicted chemotherapy response and poor outcomes, outperforming traditional clinicopathologic features. Additionally, a pan-cancer analysis affirmed the relevance of our hypoxia-related genes across multiple malignancies, particularly highlighting KRTCAP2 as a pivotal biomarker associated with worse prognosis and reduced immune infiltration.
Conclusion
Our findings underscored the prognostic potential of hypoxia-related model and offered a novel avenue for therapeutic targeting, aiming to ameliorate outcomes in pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Heming Ge, Cenap Güngör
Zitieren
APA
Ge, H., Wolters-Eisfeld, G., Hackert, T., Li, Y., & Güngör, C. (2025). Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer. PLOS One, 20(5), e0322618. https://doi.org/10.1371/journal.pone.0322618
Vancouver
Ge H, Wolters-Eisfeld G, Hackert T, Li Y, Güngör C. Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer. PLOS One. 2025;20(5):e0322618. doi:10.1371/journal.pone.0322618
BibTeX
@article{Ge2025,
author = {Ge, Heming and Wolters-Eisfeld, Gerrit and Hackert, Thilo and Li, Yuqiang and Güngör, Cenap},
title = {Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {5},
pages = {e0322618},
doi = {10.1371/journal.pone.0322618}
}
EUVIMED